NCT01917877View on ClinicalTrials.gov

Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2013

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Pulmonary Fibrosis
Interventions
DRUG

Bevacizumab

Bevacizumab 7mg/kg iv on day1 and 21, followed by Dexamethasone 10mg iv d 1-10, then 5mg iv d11-15, 2.5mg iv d16-20

DRUG

Dexamethasone

Dexamethasone 10mg iv d 1-10, then 5mg iv d11-15, 2.5mg iv d16-20

Trial Locations (1)

266042

RECRUITING

Qingdao Central Hospital, Qingdao

All Listed Sponsors
lead

Qingdao Central Hospital

OTHER